Allergan Aesthetics Enters into Option to Acquire Cypris Medical

Posted By American Med Spa Association, Wednesday, January 13, 2021

Allergan Aesthetics, an AbbVie company, has announced that it has entered into a warrant agreement with Cypris Medical, a privately held medical device company based in Chicago. Following the completion of a clinical trial to be initiated in 2021, Allergan Aesthetics will have the right to exercise an option to acquire Cypris Medical, including the company's Xact device. The planned clinical trial will evaluate the safety and effectiveness of Xact in treating mid-face descent, as well as for neck lifts.
Replacing the scalpel, Xact is designed to allow for lifting and suturing of the superficial muscular aponeurotic system (SMAS), the same tissue mobilized in a facelift, but in a minimally-invasive manner. The innovative technology intends to provide patients surgery-like results in the office with little to no downtime.
Read more at PR Newswire >>